SlideShare a Scribd company logo
Chemical Services Case Study
Background
Covance was approached by a client with a synthetic graphite nanotube used in specialized applications
who needed to register it in the European Union under REACH (Registration, Evaluation, Authorization
and restriction of Chemicals) regulation. Although graphite is already registered under REACH, these
tubules were clearly nanomaterials and therefore required a specialized REACH registration.
The Challenges
The challenges that confronted Covance were:
▶ Identifying and negotiating to join a SIEF (Substance Information Exchange Forum):
As REACH mandates a one-submission, one-substance approach, registrants of substances must ascertain if their
substance is already registered by submitting a letter of enquiry to ECHA (European Chemicals Agency). If a
substance is already registered, then it is necessary to negotiate with the SIEF to become a joint member to enable
submission under a lead registrant.
▶ Establishing substance identity:
To enable Covance to confirm if the substance was already registered under REACH, a detailed characterization of
the substance was required. For nanomaterials, the analytical approach requires the use of a range of techniques
not usually performed for conventional substances. Identifying the appropriate analytical tests and the subsequent
interpretation of the results can be challenging.
▶ Interpreting complex technical data in the context of the regulations on nanomaterials:
Interpretation of highly technical data in the context of REACH regulation requires scientific and regulatory
expertise. In addition, it can be challenging to present this effectively within the constraints of a REACH dossier
submission.
The Solutions
Covance’s experience with REACH regulations, SIEF engagement and capability in interpreting technical
physicochemical data for nanomaterials ensured successful dossier submission.
Covance’s extensive experience with REACH ensured smooth and timely entry into the appropriate SIEF
With the analytical data available, Covance used their technical know-how and understanding of the REACH system
to conduct a detailed comparison of the characteristics of their client’s nanomaterial against previously registered
carbon nanotubes. This comparison of nanoforms enabled Covance to identify the appropriate SIEF. Covance then
approached and negotiated entry into the SIEF to enable the submission of a joint member dossier.
NAVIGATING NANOMATERIALS
THROUGH REACH
Covance’s experience in regulatory submissions and their technical insight enabled the
submission of a highly complex joint member dossier, in line with REACH requirements
for nanomaterials
Joint member dossiers are usually straightforward, but for nanomaterials, specific information,
beyond what is usually required on substance identity and characterization, is needed. For most
substances, spectral analyses e.g., UV-visible and infrared spectroscopy and NMR (nuclear magnetic
resonance) are used to confirm structure with chromatographic analysis being used to assess purity. 	
For this carbon nanotube, Covance interpreted and summarised an extensive array of
physicochemical characterisation data including, transmission electron microscopy, Raman
spectroscopy, energy dispersive spectroscopy, X-ray diffraction, particle size analysis, pore volume
analysis and gas chromatography-mass spectrometry analysis. This enabled Covance to create a
dossier that described the substance dimensions (both external and internal, as it consisted of a
tube within a tube); crystallinity, particle size, surface area (from gas absorption methodologies),
impurities, carbon content not in the form of tubes (i.e., unreacted carbon), metal and non-
metallic content. Covance were able to take the extensive and highly technical physicochemical and
structural data and present it coherently within the joint member dossier, ensuring that all relevant
interpretation required for regulatory review was provided.
Conclusions
Covance applied its scientific and regulatory insight to create a dossier for a carbon nanotube
aligned with the ECHA legislative requirements for nanomaterials. By keeping pace with regulatory
and scientific innovations, Covance yet again delivered excellent service for clients.
Visit www.covance.com/chemical to find out more.
Covance is the drug, medical device and diagnostics business segment of LabCorp, a leading
global life sciences company. COVANCE is a registered trademark and the marketing name
for Covance Inc. and its subsidiaries around the world.
The Americas +1.888.COVANCE (+1.888.268.2623)  +1.609.452.4440
Europe/Africa  +00.800.2682.2682 +44.1423.500888
Asia Pacific  +800.6568.3000 +65.6.5686588
© Copyright 2019 Covance Inc. CSCPC005-0819

More Related Content

Similar to Navigating Nanomaterials Through REACH - Chemical Services Case Study

REACH - Enforceability of new restrictions
REACH - Enforceability of new restrictionsREACH - Enforceability of new restrictions
REACH - Enforceability of new restrictions
Lorenzo Zullo
 
UN application questions
UN application questionsUN application questions
UN application questions
KAIST
 
Carbon analysis cod toc bod sensor-wtw
Carbon analysis cod toc bod sensor-wtwCarbon analysis cod toc bod sensor-wtw
Carbon analysis cod toc bod sensor-wtw
ENVIMART
 
Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020
Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020
Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020
RemadylProject
 
Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...
Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...
Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...
raj takhar
 
Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...
Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...
Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...
KTN
 
Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...
Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...
Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...
Chemistry Matters Inc.
 
Andersson, Erik: Requirements for in-situ observations to support the Coperni...
Andersson, Erik: Requirements for in-situ observations to support the Coperni...Andersson, Erik: Requirements for in-situ observations to support the Coperni...
Andersson, Erik: Requirements for in-situ observations to support the Coperni...
Integrated Carbon Observation System (ICOS)
 
UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...
UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...
UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...
UK Carbon Capture and Storage Research Centre
 
Communications Regulatory Agency, Bosnia and Herzegovina
Communications Regulatory Agency, Bosnia and HerzegovinaCommunications Regulatory Agency, Bosnia and Herzegovina
Communications Regulatory Agency, Bosnia and Herzegovina
AlexMinov
 
techUK Environment and Compliance Programme
techUK Environment and Compliance ProgrammetechUK Environment and Compliance Programme
techUK Environment and Compliance Programme
techUK
 
Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020
crovida
 
Physical Contaminants Final Report
Physical Contaminants Final ReportPhysical Contaminants Final Report
Physical Contaminants Final ReportMary Dimambro
 
Prototype SMS Based Fluid Parameter monitoring system.pptx
Prototype SMS Based Fluid Parameter monitoring system.pptxPrototype SMS Based Fluid Parameter monitoring system.pptx
Prototype SMS Based Fluid Parameter monitoring system.pptx
LoisDavid2
 
R_ActCH03_ARQD_12Mar2015
R_ActCH03_ARQD_12Mar2015R_ActCH03_ARQD_12Mar2015
R_ActCH03_ARQD_12Mar2015Kulbir Banwait
 
Progress on VOC Control and Management for the Petrochemical Industry In China
 Progress on VOC Control and Management for the Petrochemical Industry In China  Progress on VOC Control and Management for the Petrochemical Industry In China
Progress on VOC Control and Management for the Petrochemical Industry In China
BREEZE Software
 
In Compliance Magazine - RoHS Status Article
In Compliance Magazine - RoHS Status ArticleIn Compliance Magazine - RoHS Status Article
In Compliance Magazine - RoHS Status Article
kbots
 

Similar to Navigating Nanomaterials Through REACH - Chemical Services Case Study (20)

REACH - Enforceability of new restrictions
REACH - Enforceability of new restrictionsREACH - Enforceability of new restrictions
REACH - Enforceability of new restrictions
 
UN application questions
UN application questionsUN application questions
UN application questions
 
Carbon analysis cod toc bod sensor-wtw
Carbon analysis cod toc bod sensor-wtwCarbon analysis cod toc bod sensor-wtw
Carbon analysis cod toc bod sensor-wtw
 
Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020
Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020
Remadyl at @Global PVC Compounding and Production Cycle Forum 15-16.06.2020
 
Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...
Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...
Technical Status Quo of the SCIP Database, Dissemination Platform & Software ...
 
Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...
Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...
Accelerating to Net Zero with Hydrogen Blending Standards Development in the ...
 
Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...
Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...
Use of GCxGC-TOFMS in litigious mixed condensate plumes: Environmental forens...
 
140926 ercc2 workshopreport
140926 ercc2 workshopreport140926 ercc2 workshopreport
140926 ercc2 workshopreport
 
Andersson, Erik: Requirements for in-situ observations to support the Coperni...
Andersson, Erik: Requirements for in-situ observations to support the Coperni...Andersson, Erik: Requirements for in-situ observations to support the Coperni...
Andersson, Erik: Requirements for in-situ observations to support the Coperni...
 
Subsea leak detection systems
Subsea leak detection systemsSubsea leak detection systems
Subsea leak detection systems
 
UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...
UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...
UK Norway Collaboration Post-Combustion Carbon Capture Using MOFs, Carlos Gra...
 
Communications Regulatory Agency, Bosnia and Herzegovina
Communications Regulatory Agency, Bosnia and HerzegovinaCommunications Regulatory Agency, Bosnia and Herzegovina
Communications Regulatory Agency, Bosnia and Herzegovina
 
techUK Environment and Compliance Programme
techUK Environment and Compliance ProgrammetechUK Environment and Compliance Programme
techUK Environment and Compliance Programme
 
Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020
 
Physical Contaminants Final Report
Physical Contaminants Final ReportPhysical Contaminants Final Report
Physical Contaminants Final Report
 
Prototype SMS Based Fluid Parameter monitoring system.pptx
Prototype SMS Based Fluid Parameter monitoring system.pptxPrototype SMS Based Fluid Parameter monitoring system.pptx
Prototype SMS Based Fluid Parameter monitoring system.pptx
 
R_ActCH03_ARQD_12Mar2015
R_ActCH03_ARQD_12Mar2015R_ActCH03_ARQD_12Mar2015
R_ActCH03_ARQD_12Mar2015
 
Qatar petroleum presentation
Qatar petroleum presentationQatar petroleum presentation
Qatar petroleum presentation
 
Progress on VOC Control and Management for the Petrochemical Industry In China
 Progress on VOC Control and Management for the Petrochemical Industry In China  Progress on VOC Control and Management for the Petrochemical Industry In China
Progress on VOC Control and Management for the Petrochemical Industry In China
 
In Compliance Magazine - RoHS Status Article
In Compliance Magazine - RoHS Status ArticleIn Compliance Magazine - RoHS Status Article
In Compliance Magazine - RoHS Status Article
 

More from Covance

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Covance
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
Covance
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Covance
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
Covance
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
Covance
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
Covance
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
Covance
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
Covance
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
Covance
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
Covance
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
Covance
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Covance
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Covance
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Covance
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Covance
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
Covance
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
Covance
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
Covance
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
Covance
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
Covance
 

More from Covance (20)

Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
Accelerate Your Scientific Discovery with GlobalCODE® - A Unique Data Managem...
 
Genomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome AnalysisGenomics Solutions - Single Target to Whole Genome Analysis
Genomics Solutions - Single Target to Whole Genome Analysis
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
Pharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for BiosimilarsPharmacovigilance Risk Management for Biosimilars
Pharmacovigilance Risk Management for Biosimilars
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Cell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise SolutionsCell & Gene Therapy Enterprise Solutions
Cell & Gene Therapy Enterprise Solutions
 
Cell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development SolutionsCell & Gene Therapy Clinical Development Solutions
Cell & Gene Therapy Clinical Development Solutions
 
Inhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory TreatmentsInhalation Technology - The Future of Effective Respiratory Treatments
Inhalation Technology - The Future of Effective Respiratory Treatments
 
Covance Laboratory FSPx Solutions
Covance Laboratory FSPx SolutionsCovance Laboratory FSPx Solutions
Covance Laboratory FSPx Solutions
 
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...
 
Environmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical DrugsEnvironmental Risk Assessment for Pharmaceutical Drugs
Environmental Risk Assessment for Pharmaceutical Drugs
 
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...
 
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramPutting the Patient First: Launching a Comprehensive Patient-Centric Program
Putting the Patient First: Launching a Comprehensive Patient-Centric Program
 
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketTop 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty Market
 
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...
 
Covance Phase IV Solutions Brochure
Covance Phase IV Solutions BrochureCovance Phase IV Solutions Brochure
Covance Phase IV Solutions Brochure
 
Optimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access ExperienceOptimizing Each Patient's Product Access Experience
Optimizing Each Patient's Product Access Experience
 
Patient Safety Cloud Solution Brochure
Patient Safety Cloud Solution BrochurePatient Safety Cloud Solution Brochure
Patient Safety Cloud Solution Brochure
 
Plant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant CultivationPlant Metabolism Studies: Options for Plant Cultivation
Plant Metabolism Studies: Options for Plant Cultivation
 
Biocide Authorization Timeline
Biocide Authorization TimelineBiocide Authorization Timeline
Biocide Authorization Timeline
 

Recently uploaded

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 

Recently uploaded (20)

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 

Navigating Nanomaterials Through REACH - Chemical Services Case Study

  • 1. Chemical Services Case Study Background Covance was approached by a client with a synthetic graphite nanotube used in specialized applications who needed to register it in the European Union under REACH (Registration, Evaluation, Authorization and restriction of Chemicals) regulation. Although graphite is already registered under REACH, these tubules were clearly nanomaterials and therefore required a specialized REACH registration. The Challenges The challenges that confronted Covance were: ▶ Identifying and negotiating to join a SIEF (Substance Information Exchange Forum): As REACH mandates a one-submission, one-substance approach, registrants of substances must ascertain if their substance is already registered by submitting a letter of enquiry to ECHA (European Chemicals Agency). If a substance is already registered, then it is necessary to negotiate with the SIEF to become a joint member to enable submission under a lead registrant. ▶ Establishing substance identity: To enable Covance to confirm if the substance was already registered under REACH, a detailed characterization of the substance was required. For nanomaterials, the analytical approach requires the use of a range of techniques not usually performed for conventional substances. Identifying the appropriate analytical tests and the subsequent interpretation of the results can be challenging. ▶ Interpreting complex technical data in the context of the regulations on nanomaterials: Interpretation of highly technical data in the context of REACH regulation requires scientific and regulatory expertise. In addition, it can be challenging to present this effectively within the constraints of a REACH dossier submission. The Solutions Covance’s experience with REACH regulations, SIEF engagement and capability in interpreting technical physicochemical data for nanomaterials ensured successful dossier submission. Covance’s extensive experience with REACH ensured smooth and timely entry into the appropriate SIEF With the analytical data available, Covance used their technical know-how and understanding of the REACH system to conduct a detailed comparison of the characteristics of their client’s nanomaterial against previously registered carbon nanotubes. This comparison of nanoforms enabled Covance to identify the appropriate SIEF. Covance then approached and negotiated entry into the SIEF to enable the submission of a joint member dossier. NAVIGATING NANOMATERIALS THROUGH REACH
  • 2. Covance’s experience in regulatory submissions and their technical insight enabled the submission of a highly complex joint member dossier, in line with REACH requirements for nanomaterials Joint member dossiers are usually straightforward, but for nanomaterials, specific information, beyond what is usually required on substance identity and characterization, is needed. For most substances, spectral analyses e.g., UV-visible and infrared spectroscopy and NMR (nuclear magnetic resonance) are used to confirm structure with chromatographic analysis being used to assess purity. For this carbon nanotube, Covance interpreted and summarised an extensive array of physicochemical characterisation data including, transmission electron microscopy, Raman spectroscopy, energy dispersive spectroscopy, X-ray diffraction, particle size analysis, pore volume analysis and gas chromatography-mass spectrometry analysis. This enabled Covance to create a dossier that described the substance dimensions (both external and internal, as it consisted of a tube within a tube); crystallinity, particle size, surface area (from gas absorption methodologies), impurities, carbon content not in the form of tubes (i.e., unreacted carbon), metal and non- metallic content. Covance were able to take the extensive and highly technical physicochemical and structural data and present it coherently within the joint member dossier, ensuring that all relevant interpretation required for regulatory review was provided. Conclusions Covance applied its scientific and regulatory insight to create a dossier for a carbon nanotube aligned with the ECHA legislative requirements for nanomaterials. By keeping pace with regulatory and scientific innovations, Covance yet again delivered excellent service for clients. Visit www.covance.com/chemical to find out more. Covance is the drug, medical device and diagnostics business segment of LabCorp, a leading global life sciences company. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world. The Americas +1.888.COVANCE (+1.888.268.2623)  +1.609.452.4440 Europe/Africa  +00.800.2682.2682 +44.1423.500888 Asia Pacific  +800.6568.3000 +65.6.5686588 © Copyright 2019 Covance Inc. CSCPC005-0819